A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects
Clinical trial NCT04457180 · COMPLETED
Trial details
- NCT number
- NCT04457180
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2021-05-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.